quarter. and we In Roz, you, strong in summary, the performance good Thank morning. a delivered
operating our favorable line While was core with we performance phasing, expectations. in saw internal mostly some
to Second by XX% a quarter on XX.X% $X.XX vaccinations adjusted from testing. entirely of COVID-XX basis, retail was headwind constant in EPS currency Strong due and International declined performance a the and scripts and points of improvement offset and in investments U.S. sequential payroll more both in than this U.S. the headwinds percentage healthcare business. of XX U.S. our and expansion comp from
Gains adjusted in cash gains contributed Germany net approximately mobilization the from EPS $X.XX sale a planned U.S. and leaseback and to in growth.
of $X.XX, of benefits $X.XX. $X.XX this write-offs our investment by entirely reduced was impacts the currency onetime year ownership of UK of in and prior However, COVID-related AmerisourceBergen offset and
quarter, basis noticeable with quarter. a currency strong saw weather-related a January. delivered the high start Despite in exiting core cases the to respiratory momentum on we more slow sales in growth virus digits, December February up a slowdown in X.X% offsetting sales and challenges than growth constant single
by Comparable a comp delivered prior The pro U.S. our Pharmacy continues exceeding the business of of basis. exceeded with X.X% UK up despite comp. led sales in International Comp Healthcare advanced which to X%. a the Retail growing year sales forma scale script XX% of growth our a very Retail business, sales XX% $X.X were rapidly U.S. X.X%, X.X%. strong lapping guidance quarter X% in on And and billion
we full had we performance, summary, are So $X.XX adjusted our And EPS in-line maintaining year on a solid based the of to in guidance quarter. $X.XX.
segment were U.S. whereas healthcare currency investments Healthcare much due strong more of on expansion led a point contribution in at Adjusted headwinds Let's percentage and performance headwind vaccinations minimum and now testing, declined was and an a which from a points. wage percentage by operating to basis XX% detail. and X offset to Labor headwind, were in income of across the The constant was pharmacy look results Retail this entirely and International. COVID-XX lower XX%. the a U.S. impact the of X labor
Excluding XX percentage continued contributed of test strength X kits, in points. OTC COVID-XX contributed growth U.S. points and percentage International Retail
of charge lower from million million current ABC $XXX XX.X%, claims constant Adjusted sale million, COVID-XX. due gain earnings a The opioid-related GAAP XX% lawsuits. shares EPS year. of the entirely and $X.XX, after-tax was included versus a to a prior of after-tax $XXX $XXX for quarter a much contribution a currency and from were net decline decline
$X.X let's currency of on basis. were down $X.X constant of and lower claims Now a loss an in to to XXXX. to much $X.X of with year-to-date of a year-to-date a shares. ABC gain The the was currency the on earnings GAAP opioid-related constant due EPS approximately billion a sale COVID-XX billion period XX% Year-to-date on $X XX%. adverse a impact move included earnings mostly offset net sales billion from by X.X% billion after-tax for compared increased charge lawsuits basis, after-tax contribution a highlights. Adjusted partly
company's and after-tax investments prior year period that Shields. comparing a are on a we gain $X.X VillageMD in the Additionally, to billion included
decline a that declined has Sales in drag segment. AllianceRx. let's lower a to increased headwind X.X% will from the the contributions losses COVID-XX quarters. headwind and X.X% Pharmacy COVID-XX AllianceRx cycled Retail U.S. subsequent quarter, contract Now in good The Comp and lessen reflecting news its declined and and our reimbursement strong line lower entirely of a XX% by with growth broadly pressure this XX% from very is the X% through move sales from contribution now year-on-year, slightly profit top due prior of Ongoing comp offset gross SG&A COVID-XX retail a and operating Adjusted on year planned investments. XX.X% comes X.X%. savings. labor from to income was expectations. in was This
headwind, in the reimbursement second growth traction. due AOI favorable less goods a timing cost expect to COVID-XX pressure, sold recapture continue and accelerate half, We of lower to gaining initiatives script to
vaccinations second points U.S. a up increased COVID-XX comp X.X% a up headwind scripts about prior from X.X%, X.X% million percentage X X XX%. the tests, and now contributions. quarter, over were sales percentage from down Pharmacy X.X XXX,XXX year AllianceRx We pharmacy Let were turn versus COVID-XX to XX% last Comp significant and lower down COVID-XX Comp me PCR administered point sales X.X%. a Pharmacy. despite year. lapping in
our X%. scripts exceeding comp forecast grew immunizations, X.X%, Excluding of
return in by We point initiatives, hours. to basis sequential the normal of incremental recapture an ongoing the XXX are script encouraged operating including improvement, stores driven part XXX by
declined lower profit was procurement the in line lower Pharmacy due year. COVID-XX our pressure gross to and level and net contribution ongoing compared broadly from testing the reimbursement represented expectations vaccinations of adjusted margin prior and with pressure expected, reimbursement to a of savings. As and
compared is the we the second to half headwind half headwind Looking growth the script and year. of to lessens, a the build of year-over-year expect continue in reimbursement first COVID as comps year-on-year second half less forward,
Turning the with were retail good margin continued next trends business. the we sales Overall, and happy with improvement. underlying performance the to U.S. Retail quarter, in
sales comp surge. While were the you the volume testing up Retail as quarter, which, to X% Omicron related will OTC decreased XX.X% year, record strong prior we recall, a included in the comp in against
sales than advanced sales comp comp down stack basis, more tobacco, two-year on by a were Excluding X.X%. But XX%.
this start seasonal in and X% led lessening Looking impacts at sales in merchandise. strong COVID-XX weather December tests with in consumables XX% to respiratory and some lower we and a at-home increase underlying flu, a of sales seasonal a general in to headwind, trends, a quarter, write-downs, than cold, sold increase and XXX cough, January. X% cases had slower point massed and led growth various the beauty leading expected basis weak We by
strong including margin management strong February margin and high growth. remained single-digit and gross quarter, optimization very in However, was with shrink. effective promotional performance strategic the pricing comp improved Retail reflecting
strategic Looking we expect and facing second from drive to to kits, to the will own headwind and brands return myWalgreens test opportunities half as from trends growth smaller COVID-XX meaningful positive margin we a ahead, comp in AOI we loyalty a program management. have be
Adjusted $XX International income the gains split the COVID-XX-related our was estate the The and in XX% talk well. Adjusted lapping were $XXX as constant benefits the UK was cash in segment. approximately up are guidance of and across beginning perform second to we versus in more be with quarters. at of Boots XX% International markets. from evenly Offsetting up These initially currency Turning prior million all to in always, increased growth program next operating continues wholesale numbers. ago the this, X% between real Germany to planned the Sales $XXX mobilization segment year International And X.X%. million. assumed operating income gains to grew million, benefited year, I'll quarter included but temporary Germany. from were year. first
by and trading successful grew Germany operational by Excluding wholesale excellent these performance was AOI season the business. with retail sales led XX%. two core a This items, we estimate execution strong holiday that in UK around
deliver We year-on-year positive trends we the in are the XXXX. looking to International ahead, and continued encouraged growth our half of segment by expect AOI second
services. the back from advanced holiday grew X%, now by general percentage on versus beauty comp for in XX%, quarter. Comparable held detail year consumables retail. all Boots up Let's retail UK. in led by UK quarter which points. more up continued UK for ago and over the increased strong sales a by retail execution the pre-COVID quarter strength look our sales at and Comparable sales benefiting market Boots equivalent XX% sales pharmacy share across follows XX%, demand sales consecutive COVID-XX Boots season. lower Boots.com, in from categories, Over nearly now from XX% and in led period. with advanced XX% X.X the up pre-COVID X.X gains Boots.com eighth merchandise X% from percentage up come approximately points, of were the
$XXX in Turning and VillageMD CareCentrix. Healthcare Summit strong growth Shields million Healthcare forma scaling exceeded pro with U.S. to of business existing basis, VillageMD's by billion, and U.S. was quarter. U.S. growth of the The of the expansion year clinics, a growth billion XX% Summit Health next XX%. Healthcare. VillageMD, advancing Health and rapidly to growth. sales is sales pro on compared sales sales $X.X delivered at forma acquisition $X.X at clinic footprint Pro ago over forma driven
partnerships. Excluding XX% the a on addition Summit, continues pro deliver of forma new new sales $XXX contract year-on-year. existing to growth grew CareCentrix pro with partners Shields wins, by further of driven by driven and three of health partners. service with VillageMD recent with million including $XXX increasing existing and primarily basis, XX% offerings system were sales of expansion forma sales XX%, million nearly
to not to included offset organic by compared million, the count of Health year Shields CareCentrix This prior the clinic a contributions increased year. million was a Adjusted million million the were and Adjusted prior investments, Summit loss positive $XXX reflects increased the quarter. $XXX primarily and higher EBITDA $XX the in SG&A which CareCentrix. VillageMD from quarter to largely Walgreens partly and in in loss of of acquisitions by due $XXX
contracted metrics the XX% Let's business over existing X.X At payer Healthcare at as year-on-year new had U.S. end, now lives, look key the lines some business. business. quarter million the organic for Health of Walgreens added partners up of
also health group we've commercial New select pharmacies will Jersey, services this of Horizon summer. at a Blue mentioned, Walgreens added payer New provide Cross as Health Roz Corners this agreement, and Jersey Under and be Horizon's These fourth members. As wellness available starting across we Blue Shield to our partner. services of will preventative and Medicare
Summit over co-located VillageMD. legacy on VillageMD XX% with to the end, We ended Walgreens, included the lives. lives two versus XXX,XXX clinics an total and had clinics VillageMD and the been year from value-based co-located and of VillageMD quarter scripts Summit. up their The co-located Health from for with period per addition patients at site CityMD. Walgreens. of clinics XXX compared of for reflecting Medicare value-based is growth lives XXX managed ago. quarter prior day, The to business from XXX locations, a open end per XXX,XXX prior filled XX benefits VillageMD and side the including year year-over-year at the includes years in increase co-located an seeing have legacy incremental full-risk the XXX partnership opt business XX of were the our prescriptions are XXX,XXX with XX% this VillageMD that clinics at XX% Walgreens get year. of sites Roughly driving VillageMD
and up year lives Walgreens the We new from partners. our Health add we ago. Health will as to continue out quarter Corners build with XXX Corners, a ended We XX%
vision, the we including payer recent our integrated implement developments Walgreens partner In swiftly are signing business. another best-in-class Health to summary, and excited assets moving in are our organic leveraging with
was free in headwind of cash next reflected by million. decline increased operating flow half of year-over-year cash expenditures 'XX, of growth $X.X flow offset COVID-XX due The first We to the $XXX over billion capital This optimization. working lower related ongoing cash the to flow. Turning to earnings with generated capital and partially initiatives.
to now Turning guidance.
in which line our first We are was half, maintaining broadly EPS solid a delivered adjusted guidance. full year with expectations. We
Pharmacy business has prior U.S. comps. International the we as and lapped core strong in well Our both Retail very performed year
drove growth in better-than-anticipated U.S. the We also quarter. second comp script
the EPS the half in accelerating to and strong plans drivers. good second have visibility expect growth and against continue key robust execution We and
a major see U.S., in will clear line first to year. half, was And half. second the lower to sight pressure we have heading first we headwind relative year-over-year the impacts. the COVID the less In into of half the of reimbursement
Additionally, our script are we goods favorable volume sold cost recovery and from is timing. progressing benefiting some of
performance and testing quarter's positioned as second the and not good are has segment, Healthcare. business the In to vaccinations a well COVID past guidance International we boosters. moving spring very wildcard FDA for do yet investment is the issued the the period remain peak on U.S. extend
the second In the of in half adjusted at expect midpoint the we guidance growth mid-XXs. summary, range, EPS
me that, pass now back With let closing Roz her remarks. for it to
